Opioid-use Disorder Clinical Trial
— FORCEOfficial title:
FAVOR Opioid Recovery Coaching Evaluation
Verified date | February 2019 |
Source | Greenville Health System |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Emergency Department (ED) is an ideal location to identify patients in need of treatment
for opioid addiction. A local non-profit community-based addiction recovery program, Faces
and Voices of Recovery (FAVOR) utilizes a peer recovery coaching model applied to substance
use disorders by identifying, training, credentialing and supervising individuals who have
been in recovery for at least 2 years.
These peer recovery coaches become the primary workforce in this community-based model. FAVOR
provides no-cost comprehensive services for addiction recovery. The investigators
hypothesized that having FAVOR Recovery Coaches (FRC) evaluate patients during an ED visit
for opioid overdose would result in a high degree of engagement from the patients and serve
as an opportunity to begin treatment for addiction.
Status | Completed |
Enrollment | 150 |
Est. completion date | December 31, 2018 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients presenting to the ED with opioid overdose or withdrawal Exclusion Criteria: - Age <18 - Known pregnant female - Prisoners |
Country | Name | City | State |
---|---|---|---|
United States | Greenville Health System | Greenville | South Carolina |
Lead Sponsor | Collaborator |
---|---|
Greenville Health System | FAVOR (Faces and Voices of Recovery) OF GREENVILLE, South Carolina Department of Alcohol and Other Drug Abuse Services |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of patients with active involvement in recovery | Defined as: Patients who have had phone, email, or in-person contact with their FAVOR recovery coach after discharge from the Emergency Department. | One year | |
Secondary | All-cause Mortality | Number of participants with death from any cause within the study period. | One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04157062 -
An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder
|
N/A | |
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Completed |
NCT04505540 -
Start Treatment and Recovery for Opioid Use Disorder
|
N/A | |
Completed |
NCT03065049 -
Transforming Recovery Through Exercise and Community
|
N/A | |
Completed |
NCT04080037 -
Assessing Opioid Care Practices Using CPV Patient Simulation Modules
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
Active, not recruiting |
NCT04650386 -
Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients
|
N/A | |
Completed |
NCT03715634 -
Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
|
Phase 1 | |
Enrolling by invitation |
NCT04991974 -
Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine
|
Phase 2/Phase 3 | |
Completed |
NCT04122755 -
Single Ascending Dose Study of ALA-1000
|
Phase 1 | |
Recruiting |
NCT05028998 -
COVID-19-Related Opioid Treatment Policy Evaluation
|
||
Recruiting |
NCT05049460 -
Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder
|
N/A | |
Recruiting |
NCT04927143 -
Encouraging Abstinence Behavior in a Drug Epidemic
|
Phase 2 | |
Completed |
NCT05047627 -
Digital Intervention to Treat Anxiety and Depression Among Persons Receiving Treatment for Opioid Use Disorder
|
N/A | |
Active, not recruiting |
NCT04129580 -
reSET-O RCT (Randomized Controlled Trial)
|
N/A | |
Recruiting |
NCT03923374 -
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
|
||
Completed |
NCT04464421 -
SMART Effectiveness Trial
|
N/A | |
Completed |
NCT04056182 -
Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
|
Phase 2 | |
Suspended |
NCT02687360 -
Imaging the Effects of rTMS on Chronic Pain
|
N/A |